This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Alacrita Launches 2012 Charity Auction Of One-to-One Lunches With Senior Executives From The Pharmaceutical Industry

CAMBRIDGE, Massachusetts and LONDON, December 4, 2012 /PRNewswire/ --

Life Sciences Seasonal Appeal to Raise Funds for WaterAid

Alacrita, the transatlantic firm which is changing the face of life science consulting, is delighted to launch its 2012 Life Sciences Seasonal Appeal. Alacrita is offering the unique opportunity for individuals from the life sciences industry to bid for a two-hour, one-to-one lunch with senior executives from the pharmaceutical industry.

The Appeal aims to raise money for WaterAid ( http://www.wateraid.org), an international non-profit organization that  transforms the lives of people in the world's poorest countries by improving access to safe water and sanitation. Bidding is open from Monday 3 rd December and closes on Thursday 13 th December and details are available on the Alacrita website.

Senior figures from the pharmaceutical industry who have kindly donated their time to the appeal include:

  • Heather Bell , Head of Corporate Strategy and Shaun Grady , Head of Business Development at AstraZeneca
  • Moncef Slaoui , Chairman, Research & Development at GlaxoSmithKline
  • Douglas Giordano , Senior Vice President, Worldwide Business Development at Pfizer
  • Susan Silbermann, President and General Manager, Vaccines, Specialty Care Business Unit and Polly Murphy Vice President, Specialty Care Business Unit Business Development at Pfizer
  • Graham Brazier , Vice President, Business Development, Strategic Transactions Group at Bristol-Myers Squibb
  • Pamela Demain, Executive Director, Corporate Licensing at Merck
  • Susan Jane Herbert , Executive Vice President and Head of Global Business Development and Strategy and Annalisa Jenkins , Executive Vice President and Head of Global Drug Development & Medical and Belen Garijo , Executive Vice President and Chief Operating Officer at Merck Serono

Bidding on the Alacrita auctions will be open until 13 th December, 5pm EST/ 10pm GMT.

Rob Johnson, Partner at Alacrita, said: "We are thrilled to launch this year's seasonal appeal to raise funds for WaterAid. 783 million people, or one in ten of the world's population, live without access to safe water and last year WaterAid reached 1.6 million people with water and 1.9 million people with sanitation in 27 countries. This extremely worthwhile charity has made a significant positive impact on the lives of many people around the world and we are delighted to support its tremendous work. We are also hugely appreciative to the influential industry figures who are donating their time to the appeal. The auction provides the opportunity to spend a couple of hours over lunch building relationships with key pharma decision makers, gaining valuable insights into what science excites them."

David Winder, CEO of  WaterAid ,  America,  added: "We are delighted that Alacrita has chosen to  donate the proceeds of their charity auction to  WaterAid.  Every day, 2,000 children die from water-related diseases that could easily be prevented.  The funds raised will help us reach more of the world's poorest people with safe, clean water and sanitation.  These vital basic services are essential for saving  lives, improving health and reducing poverty in the world's poorest countries."

Notes to Editors

1 of 2

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 17,079.57 -42.44 -0.25%
S&P 500 1,996.74 -3.38 -0.17%
NASDAQ 4,557.6950 -11.9260 -0.26%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs